darth vader is standing in front of a man with the words i find your lack of covfefe disturbing ALT: darth vader is standing in front of a man with the words i find your lack of covfefe disturbing

IMAGINE WHAT COULD BE- #COVFEFE!!
(Whoever named their drug #Cobenfy - LOL)

Original post on c.im

Bristol Myers Squibb, an industry stalwart in need of a hit, is betting a pill called Cobenfy can become the first approved medicine for the millions of Americans diagnosed with psychosis related to Alzheimer’s disease.
That case rests almost entirely on a single clinical trial, conducted before […]

Cobenfy for Schizophrenia: Uses, Side Effects, Dosage COBENFY is a new treatment for schizophrenia used to improve positive and negative symptoms. Includes COBENFY side effects, dose, interactions, and more.

#Cobenfy drug - there's no such current diagnosis as schizophrenia; Cobenfy is made by #Bristol Myers Squibb, #BristolMyersSquibb @bristolmyerssquibb.bsky.social @bristolmyerssquib.bsky.social which acquired it from #Karuna Therapeutics ://www.drugs.com/cobenfy.html

Xanomeline-trospium: defining its place among the current antipsychotic landscape | Acta Neuropsychiatrica | Cambridge Core Xanomeline-trospium: defining its place among the current antipsychotic landscape - Volume 37

🔗 Read the full paper: doi.org/10.1017/neu....
#Antipsychotic #Cobenfy #Xanomeline #CME

AbbVie joins BMS in taking a hard line on UK drug pricing AbbVie has said it may not launch its ovarian cancer therapy Elahere in the UK if a viable NHS price cannot be agreed with NICE.

#AbbVie #BMS #BristolMyersSquibb #UKdrugpricing #pharmagroup #newmedicines #UK #USA #ovariancancertherapy #Elahere #NHSpatients #reimbursementauthority #NICE #schizophrenia #Cobenfy #pharmacompanies #Trump #medicineprices #MHRA #VPAG #rebates #NHS #MSD #EliLilly #AstraZeneca
zurl.co/d8CQZ

I’ve seen the #Cobenfy commercial so many times that I’m starting to think I have schizophrenia. 🤦🏻‍♂️ #bigpharma #mentalheath

Has trial result burst BMS' Cobenfy bubble? Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

#mentalhealth #psychiatry #BMS #Cobenfy #xanomelinetartrateandtrospiumchloride #BristolMyersSquibb #schizophrenia #schizophreniatreatment #atypicalantipsychoticmedications #schizophreniamedications #antipsychotics #ARIStrial #adjunctivetreatmentforschizophrenia
pharmaphorum.com/news/has-tri...

@bms-news.bsky.social announced on April 22 that #Cobenfy (xanomeline and trospium chloride) failed to show significant benefit as an adjunctive treatment over placebo alongside typical antipsychotics. #schizophrenia

www.hcplive.com/view...

NEWS: Sky-high sales prospects for #BristolMyersSquibb's new #schizophrenia treatment #Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.

pharmaphorum.com/news/has-tri...

New Schizophrenia Drug Cobenfy Also Appears to Reduce Cognitive Symptoms in Patients Who Experience Them Researchers have published evidence indicating that Cobenfy, a new drug for schizophrenia approved by the FDA in September 2024, may help reduce cognitive impairments in some patients, in addition to ...

A new study indicated that #Cobenfy, a new drug for #schizophrenia approved by the FDA in September 2024, may help reduce cognitive impairments in some patients.
.
ow.ly/21Ap50UIvr9
.
@uclalibrary.bsky.social @dgsomucla.bsky.social @fda.gov

1995 Carlos, der Tyran («Aus Heiterem Himmel», ARD – ZDF @trigema) | 2024 Syrian Forces («Whitehelmets», @syriacivildefence – @X) #syncverse #synchronicity #coincidence #motion #motionsync @radiobristol.bsky.social #schizophrenia #cobenfy #abilify @scienceatbms

#MedSky #PsychSky have you had experience with #Cobenfy? The clinical trials have to start clean without any meds on board. Have any witness tapering off another antipsychotic at the same time as starting Cobenfy?

KarXT: an innovative and promising treatment for schizophrenia KarXT - Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new treatment for schizophrenia.

KarXT: an innovative and promising treatment for schizophrenia https://buff.ly/4fWb6At

Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new drug treatment for schizophrenia.
#KarXT #Cobenfy #Schizophrenia #Medication

nytimes.com

https://t.co/QlV7bfZPdg
Exciting news today as KarXT (xanomeline/trospium AKA #Cobenfy) gets the green light from FDA. Hopefully EMA, Health Canada, and other bodies to follow suit soon. Clearly there's more to be done with this, namely to demonstrate how well it works to